| 1287 |
Centers for Disease Control and Prevention |
Html |
en |
Closure of Varicella-Zoster Virus-Containing VaccinesPregnancy Registry - United States, 2013 |
Mona Marin, MD1, English D. Willis, MD2, Ann Marko2, Sonja A. Rasmussen, MD3, Stephanie R. |
| pregnancy outcomes | 0.375319 |
| English D. Willis | 0.373155 |
| Drug Administration | 0.364833 |
| vaccine adverse event | 0.409547 |
| Stephanie R. Bialek | 0.372051 |
| Karen R. Broder | 0.358617 |
| registry enrollments | 0.343216 |
| vzv-containing vaccines | 0.565082 |
| pregnant women | 0.372841 |
| vaccine virus replication | 0.362181 |
| Ann Marko | 0.340659 |
| major birth defects | 0.363313 |
| Zoonotic Infectious Diseases | 0.358314 |
| health care providers | 0.362522 |
| varicella-susceptible women | 0.465714 |
| observed average rate | 0.355684 |
| sustained high coverage | 0.361309 |
| wild-type VZV | 0.431374 |
| small risk | 0.342787 |
| varicella vaccine | 0.397193 |
| National Center | 0.359038 |
| registry | 0.420824 |
| VZV-containing vaccine | 0.342295 |
| vaccine administrations | 0.34148 |
|
| Author affiliations | 0.33848 |
| registry data | 0.352221 |
| pregnancy | 0.494787 |
| Merck/CDC Pregnancy Registry | 0.401884 |
| congenital varicella syndrome | 0.960029 |
| high-risk period | 0.412878 |
| theoretical risk | 0.396419 |
| attenuated VZV | 0.357294 |
| adverse events | 0.35873 |
| New patient enrollment | 0.357673 |
| birth defects | 0.369427 |
| Sonja A. Rasmussen | 0.374062 |
| Immunization Safety Office | 0.360683 |
| varicella-zoster virus | 0.338347 |
| live-born infants | 0.389435 |
| exposure | 0.338361 |
| traditional childbearing ages | 0.363885 |
| Adverse Event Reporting | 0.359504 |
| confidence interval | 0.36206 |
| low birth weight | 0.367482 |
| pregnancy-related vaccine | 0.341156 |
| Varivax | 0.390297 |
| Mona Marin | 0.372237 |
|
CLICK HERE |
| 6916 |
Centers for Disease Control and Prevention |
Html |
en |
Radiation: Radon in the Home |
Details on the radioactive gas radon and what you can do to protect yourself from harm. Provided by the Centers for Disease Control and Prevention. |
| customizable fact sheets | 0.259001 |
| test kit packaging | 0.268528 |
| Radon Action Plan | 0.572415 |
| lung cancer | 0.394986 |
| radon test kit | 0.496462 |
| lung cancer. EPA | 0.290032 |
| National Radon Action | 0.573646 |
| homes | 0.264421 |
| American Lung Association | 0.327022 |
| EPA Radon Hotlines | 0.497579 |
| Short-term radon test | 0.496327 |
| test results | 0.262855 |
| suction. Radon | 0.485335 |
| state radon office | 0.544047 |
| social media posts | 0.258816 |
| breathing radon | 0.509847 |
| radon kit | 0.459844 |
| radon level | 0.505378 |
| radon test kits | 0.614389 |
| radon gas | 0.544054 |
| new web page | 0.264196 |
| Long-term radon test | 0.489774 |
| Basic Radon Facts | 0.514185 |
| instances radon | 0.481778 |
|
| radon problems | 0.453516 |
| radon | 0.951534 |
| radon problem | 0.46136 |
| Radon Communication Toolkit | 0.515825 |
| average pCi/L level | 0.278044 |
| new radon web | 0.517813 |
| high radon levels | 0.48658 |
| air | 0.269864 |
| U.S. Environmental Protection | 0.25776 |
| short-term test | 0.26365 |
| cigarette smoking | 0.258731 |
| residential radon risks | 0.487992 |
| Radon Myths | 0.466195 |
| public health professionals | 0.261495 |
| radon levels | 0.782849 |
| radon information | 0.515577 |
| EPA radon web | 0.497486 |
| indoor air | 0.263046 |
| Radon forms | 0.512176 |
| lung cancer deaths | 0.276079 |
| term test kits | 0.264933 |
| radon reduction | 0.459086 |
| Surgeon General | 0.260893 |
| short-term testing | 0.259759 |
|
CLICK HERE |
| 7045 |
Centers for Disease Control and Prevention |
Html |
en |
Syphilis & MSM (Men Who Have Sex With Men) - CDC Fact Sheet |
Syphilis and MSM Fact Sheet from CDC. Why should MSM be concerned about syphilis? What is the link between syphilis and HIV? And more... |
| eye problems | 0.547967 |
| sexually transmitted infection | 0.613638 |
| severe medical problems | 0.575802 |
| sex partners | 0.544643 |
| United States | 0.6277 |
| swollen lymph nodes | 0.576604 |
| Prevention Information Network | 0.5677 |
| STD Prevention Conference | 0.578278 |
| P. O. Box | 0.565582 |
| STD information | 0.545041 |
| latent stage | 0.54451 |
| painless sores | 0.584265 |
| Transmitted Diseases Treatment | 0.571807 |
| Association (ASHA) | 0.56812 |
| fact sheet | 0.577798 |
| Disease Control | 0.58979 |
| STD Clinics | 0.545664 |
| secondary syphilis | 0.787417 |
| syphilis sores | 0.779091 |
| direct contact | 0.542343 |
| anal sex | 0.553109 |
| American Sexual Health | 0.56719 |
| sexually active man | 0.584651 |
| sexually -active person | 0.600827 |
|
| different signs | 0.584584 |
| sex partner | 0.562784 |
| Sexually Transmitted Disease | 0.589762 |
| oral sex | 0.548377 |
| MSM | 0.553645 |
| syphilis | 0.973773 |
| P&S syphilis cases | 0.797642 |
| vaginal sex | 0.58439 |
| swimming pools | 0.540599 |
| original site | 0.541567 |
| symptoms | 0.547758 |
| skin rash | 0.540632 |
| Sexually Transmitted Diseases | 0.631257 |
| STD Increases | 0.545569 |
| Tertiary syphilis | 0.768469 |
| health problems | 0.613062 |
| healthcare provider | 0.615259 |
| MMWR Recomm Rep | 0.565485 |
| Research Triangle Park | 0.565082 |
| P&S syphilis | 0.803512 |
| risk | 0.549294 |
| hot tubs | 0.541373 |
| HIV infection | 0.562322 |
|
CLICK HERE |
| 7314 |
Centers for Disease Control and Prevention |
Html |
en |
Evolution of Varicella Surveillance - Selected States, 2000-2010 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| passive case-based surveillance | 0.408496 |
| varicella case-based surveillance | 0.436445 |
| CDC | 0.42396 |
| Varicella surveillance practices | 0.46292 |
| varicella reporting | 0.421085 |
| active surveillance sites | 0.310197 |
| 1-dose varicella vaccination | 0.420486 |
| passive varicella surveillance | 0.469548 |
| actual varicella incidence | 0.42166 |
| varicella active surveillance | 0.432774 |
| state surveillance data | 0.289783 |
| VASP sites | 0.296702 |
| varicella surveillance data | 0.664399 |
| routine childhood vaccination | 0.29741 |
| state varicella surveillance | 0.532524 |
| 2-dose varicella vaccination | 0.455946 |
| overall varicella incidence | 0.434801 |
| varicella vaccine | 0.774286 |
| 2-dose varicella vaccine | 0.408294 |
| Varicella deaths | 0.369163 |
| varicella incidence | 0.721456 |
| national surveillance data | 0.300424 |
| varicella trends | 0.37185 |
| varicella epidemiology | 0.372592 |
| National varicella surveillance | 0.438539 |
|
| continuous varicella | 0.365831 |
| vaccination coverage increases | 0.293566 |
| single dose | 0.31519 |
| passive surveillance | 0.309523 |
| varicella vaccination | 0.57194 |
| consistent reporting | 0.544771 |
| United States | 0.340939 |
| passive surveillance data | 0.300652 |
| varicella vaccination status | 0.42655 |
| varicella data | 0.453851 |
| states | 0.629055 |
| National Notifiable Diseases | 0.394388 |
| national passive varicella | 0.442933 |
| varicella vaccination program | 0.506793 |
| varicella vaccination coverage | 0.56201 |
| disease severity | 0.286518 |
| consistent reporting criteria | 0.303631 |
| varicella cases | 0.544158 |
| Notifiable Diseases Surveillance | 0.416465 |
| case-based varicella surveillance | 0.425377 |
| varicella | 0.930675 |
| CDC varicella experts | 0.413305 |
| varicella disease epidemiology | 0.391932 |
| childhood vaccination schedule | 0.297076 |
|
CLICK HERE |
| 7379 |
Centers for Disease Control and Prevention |
Html |
en |
Pandemic Resources Tools - FluAid 2.0 |
FluAid is designed to assist state and local level planners in preparing for the next influenza pandemic by providing estimates of potential impact specific to their locality - CDC |
| software | 0.516625 |
| Download Stand-alone FluAid | 0.515788 |
| hospital beds | 0.478608 |
| maximum estimates | 0.497184 |
| sufficient hospital beds | 0.477245 |
| potential economic impact | 0.516629 |
| health outcomes | 0.641615 |
| necessary data specific | 0.480656 |
| outpatient visits | 0.535885 |
| general modeling philosophy | 0.479731 |
| potential impact specific | 0.593907 |
| level public health | 0.508244 |
| high risk condition | 0.485468 |
| state | 0.526028 |
| health care providers | 0.54387 |
| test version | 0.497184 |
| adverse health outcome | 0.49127 |
| influenza pandemic | 0.900051 |
| national level estimates | 0.749851 |
| public health planner | 0.488382 |
| national level model | 0.567344 |
| local level plans | 0.501764 |
| User’s Manual | 0.494661 |
| measurable economic impact | 0.502765 |
|
| national estimates | 0.508931 |
| non-high risk | 0.533774 |
| high risk | 0.557306 |
| after-the-event estimates | 0.498822 |
| gross attack rates | 0.47811 |
| national level impact | 0.519931 |
| Influenza pandemics | 0.514142 |
| influenza pandemic plan | 0.636715 |
| adverse health outcomes | 0.571102 |
| sustained human-to-human transmission | 0.487604 |
| pandemic influenza | 0.682812 |
| health care planner | 0.490443 |
| possible pandemic | 0.538755 |
| local level model | 0.619325 |
| user supply minimum | 0.482595 |
| potential impact | 0.790094 |
| influenza pandemic-related morbidity | 0.55149 |
| health care | 0.548209 |
| public health | 0.531596 |
| economic impact | 0.543038 |
| local level planners | 0.579442 |
| local health care | 0.496578 |
| local level | 0.702179 |
| FluAid | 0.623351 |
|
CLICK HERE |
| 9618 |
Centers for Disease Control and Prevention |
Html |
en |
Asthma - BRFSS 2008 - Table L5 Lifetime Asthma Prevalence Rate (Percent) and Prevalence (Number) by Race/Ethnicity and State or Territory |
BRFSS 2008 - Table L5 Lifetime Asthma Prevalence Rate (Percent) and Prevalence (Number) by Race/Ethnicity and State or Territory |
| DC Multirace NH | 0.236658 |
| AZ White NH | 0.238867 |
| ID White NH | 0.233814 |
| AK White NH | 0.239916 |
| FL Black NH | 0.236358 |
| IA White NH | 0.232927 |
| IL Black NH | 0.233156 |
| Hispanic | 0.278095 |
| ID Black NH | 0.233714 |
| AR Multirace NH | 0.238378 |
| CA Multirace NH | 0.238681 |
| AK Black NH | 0.239814 |
| CT Black NH | 0.236656 |
| AR White NH | 0.238684 |
| GA Multirace NH | 0.234428 |
| AL Black NH | 0.240837 |
| NH | 0.950326 |
| AZ Multirace NH | 0.238562 |
| HI Multirace NH | 0.234567 |
| AL White NH | 0.24094 |
| NH Multirace NH | 0.324274 |
| DC Black NH | 0.236862 |
| ID Multirace NH | 0.233556 |
| Black NH | 0.755684 |
| IL Multirace NH | 0.232957 |
|
| Multirace NH | 0.754224 |
| CT White NH | 0.236757 |
| IL White NH | 0.233256 |
| AR Black NH | 0.238582 |
| Total** Multirace NH | 0.241146 |
| Total** Black NH | 0.24136 |
| GA White NH | 0.234729 |
| GA Black NH | 0.234628 |
| DC White NH | 0.236963 |
| IA Black NH | 0.232826 |
| NH White NH | 0.324723 |
| CA White NH | 0.238988 |
| AK Multirace NH | 0.239652 |
| AZ Black NH | 0.238765 |
| HI White NH | 0.234826 |
| Total** White NH | 0.241467 |
| AL Multirace NH | 0.240631 |
| CT Multirace NH | 0.236454 |
| HI Black NH | 0.234726 |
| FL Multirace NH | 0.236155 |
| CA Black NH | 0.238886 |
| FL White NH | 0.236459 |
| NH Black NH | 0.324549 |
| White NH | 0.756695 |
|
CLICK HERE |
| 10224 |
Centers for Disease Control and Prevention |
Html |
en |
About CDC's Program'Extreme Heat |
Information on extreme heat. Provided by the Centers for Disease Control and Prevention (CDC) |
| extreme heat | 0.96177 |
| website | 0.290702 |
| fact | 0.293042 |
| Heat-related deaths | 0.894531 |
| United States | 0.668598 |
|
| illnesses | 0.377883 |
| resources | 0.288987 |
| information | 0.28963 |
| helpful tips | 0.712284 |
|
CLICK HERE |
| 10314 |
Centers for Disease Control and Prevention |
Html |
en |
HAN Archive - 00326 - Hantavirus Pulmonary Syndrome Cases Associated with Staying in Yosemite National Park, California |
Health Alert Network (HAN). Provided by the Centers for Disease Control and Prevention (CDC). |
| non-cardiogenic pulmonary edema | 0.410483 |
| rodent urine | 0.333831 |
| Yosemite National Park | 0.971705 |
| canvas exterior sides | 0.407488 |
| clinically compatible illnesses | 0.407381 |
| Disease Control | 0.440059 |
| deer mice | 0.322578 |
| state health departments | 0.460252 |
| CDC’s Hantavirus | 0.397286 |
| CDC document | 0.363483 |
| ill persons | 0.341538 |
| health care providers | 0.467445 |
| additional information | 0.314082 |
| bilateral interstitial infiltrates | 0.418547 |
| gastrointestinal symptoms | 0.323338 |
| immediate medical attention | 0.405134 |
| solid walls | 0.314987 |
| Additional suspected cases | 0.428131 |
| Chest radiographs | 0.315974 |
| party exhibit symptoms | 0.416857 |
| multiple health jurisdictions | 0.456294 |
| hantavirus pulmonary syndrome | 0.49016 |
| zoonotic viral disease | 0.458433 |
| HPS symptoms | 0.662883 |
| Viral Special Pathogens | 0.41607 |
|
| California Department | 0.335239 |
| Boystown area | 0.321571 |
| CDC Health Alert | 0.548262 |
| small viral particles | 0.439265 |
| Public Health | 0.370714 |
| reportable disease | 0.329488 |
| clinical case definition | 0.402219 |
| HPS | 0.925657 |
| HAN Advisory | 0.326228 |
| enhances health decisions | 0.428261 |
| critical health issues | 0.433227 |
| state health department | 0.430434 |
| incubation period | 0.314923 |
| Notifiable Diseases | 0.316217 |
| Signature Tent Cabins | 0.948904 |
| Laboratory abnormalities | 0.314734 |
| toll-free Hantavirus Hotline | 0.435305 |
| recent exposure | 0.332952 |
| fatality rate | 0.325894 |
| National Park Service | 0.478193 |
| Current Case Definitions | 0.401042 |
| potential rodent exposure | 0.427972 |
| infected rodents | 0.33863 |
| serum LDH | 0.334131 |
|
CLICK HERE |
| 12427 |
Centers for Disease Control and Prevention |
Html |
en |
Measles | Signs and Symptoms | CDC |
null |
| feet | 0.245572 |
| Español | 0.278036 |
| hairline | 0.272903 |
| navigation Skip | 0.60009 |
| patient | 0.244689 |
| person’s fever | 0.439094 |
| fever subsides | 0.43571 |
| legs | 0.254024 |
| Signos y sÃntomas | 0.465014 |
| early sign | 0.435785 |
| flat red spots | 0.973251 |
| Koplik spots | 0.761199 |
| rest | 0.24589 |
|
| list Skip | 0.599568 |
| tiny white spots | 0.768351 |
| page options Skip | 0.815659 |
| Small raised bumps | 0.627106 |
| neck | 0.248295 |
| Fahrenheit | 0.257653 |
| symptoms | 0.35035 |
| rash | 0.423641 |
| face | 0.24318 |
| mouth | 0.325895 |
| arms | 0.246107 |
| measles infection | 0.511194 |
|
CLICK HERE |
| 13046 |
Centers for Disease Control and Prevention |
Html |
null |
Vaccines: Rubella |
Rubella vaccine info for parents, public, and healthcare professionals |
|
|
CLICK HERE |